Content about Pharmaceutics

May 9, 2010
Merck: Expanding investigational drug pipeline caused by Schering-Plough merger

Merck has more than 20 investigational drugs in late-stage development, thanks to its merger with...

May 9, 2010
Watson Pharmaceuticals' Q1 revenues up 28%

Watson Pharmaceuticals had revenues of $856.5 million in the first quarter of this year, a...

May 6, 2010
Pfizer gets a boost from Wyeth, specialty drugs in Q1

Pfizer reported $16.8 billion in revenues for first quarter 2010, a 54% increase over first...

May 5, 2010
Watson seeks approval for generic Evista

Watson Pharmaceuticals is challenging the patent covering a drug for postmenopausal women, the generic drug...

May 3, 2010
GPhA president, CEO resigns

Generic Pharmaceutical Association president and CEO Kathleen Jaeger will leave the organization effective June 30,...

May 3, 2010
Sandoz launches generic Flomax, Vancocin

Sandoz has launched a generic version of a prostate drug, the generics arm of Novartis...

March 29, 2010
Alembic gets FDA approval for RLS generic

The Food and Drug Administration has approved a generic drug for treating restless leg syndrome,...

March 29, 2010
FTC wins pay-for-delay battle

The Federal Trade Commission’s crusade against patent settlements between branded and generic drug makers moved...

March 29, 2010
Pliva Hrvastka gets tentative approval for argatroban

The Food and Drug Administration has given a tentative approval to a generic drug for...

March 29, 2010
Sandoz, GPhA weigh in on follow-on biologics provision

Many people have a lot to say about the recently passed healthcare bill, but generic...

March 28, 2010
Report: Up to 4 million patients may have received unapproved drugs

The number of patients receiving unapproved prescription drugs appears to be in the millions, according...

March 25, 2010
Walmsley to lead GSK's European consumer healthcare business

GlaxoSmithKline earlier this week named Emma Walmsley to the post of president, consumer healthcare Europe...

March 17, 2010
GPhA: Omission of 'pay-for-delay' deals in health bill 'good news for American consumers'

A ban on patent settlements between branded and generic drug companies appears to have been...

March 17, 2010
PhRMA names new chairman

The Pharmaceutical Research and Manufacturers of America elected Pfizer president and CEO Jeffrey Kindler as...

March 17, 2010
Teva to acquire Ratiopharm

Teva Pharmaceutical Industries beat out Pfizer in the race to acquire German generic drug maker...

March 16, 2010
FDA shuts down unapproved Glenmark, Konec drugs

The Food and Drug Administration has ordered two generic drug companies to stop marketing unapproved...

March 16, 2010
MiddleBrook expanding promotion of Moxatag through IncreaseRx program

MiddleBrook Pharmaceuticals plans to promote its extended-release antibiotic by expanding a Web-based marketing program, the...

March 16, 2010
Pending court ruling, Teva to delay marketing Temodar generic

Teva Pharmaceutical Industries will start marketing its version of a brain tumor drug only if...

March 15, 2010
Mylan, Takeda reach agreement on Actos, Actoplus Met patents

Mylan has settled patent litigation cases with Takeda concerning two diabetes drugs, the generic drug...

March 15, 2010
Teva seeks to market Shire's ADHD drug

Teva is hoping to get a generic drug for treating attention deficit hyperactivity disorder into...

March 15, 2010
Watson receives FDA approval for Cardizem LA generic

The Food and Drug Administration has approved a Watson Pharmaceuticals drug for hypertension, Watson announced...

March 14, 2010
Bausch & Lomb recruits two Schering-Plough leaders as CEO, chairman

Bausch & Lomb on Monday recruited two former Schering-Plough senior leaders to take the reigns...

March 14, 2010
FDA demands REMS for Bydureon

Drug makers Eli Lilly, Amylin Pharmaceuticals and Alkermes encountered a speed bump in their efforts...

March 14, 2010
Ranbaxy to launch generic Actos

India’s Ranbaxy Labs will launch a generic version of a diabetes drug in two years,...

March 14, 2010
Rx suppliers prepare for patent-protection storm

Drug companies stand to lose a lot of money in the coming years, as the...

© 2013 Drug Store News. All Rights Reserved.